A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne
Launched by BIONOU RESEARCH, S.L. · Mar 15, 2019
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signature of informed consent by the patient (and their legal guardian in case of being under age).
- • Age between 12 and 30 years-old.
- • Moderate acne according to the AGSS (Acne Global Severity Scale) and / or GAGS (Global Acne Grading System) scales.
- Exclusion Criteria:
- • Contraindication of any of the components of the product under study.
- • Topical or systemic use of antifungals and antibiotics in the previous 2 weeks.
- • Consumption of probiotics in the previous 2 months.
- • Use of systemic retinoids in the previous 6 months.
About Bionou Research, S.L.
Bionou Research, S.L. is a leading clinical trial sponsor dedicated to advancing innovative therapies through rigorous research and development. With a strong focus on biotechnology and pharmaceutical sectors, the company specializes in designing and conducting clinical trials that adhere to the highest standards of regulatory compliance and ethical practices. Bionou Research leverages a multidisciplinary team of experts to ensure the successful progression of clinical studies, aiming to bring novel treatments to market that address unmet medical needs. Committed to collaboration and transparency, Bionou Research fosters partnerships with stakeholders across the healthcare landscape to enhance patient outcomes and drive scientific advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Valencia, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials
Related Blog Entries
View all
